Trade Marks in FemTech: Building Brand Trust in Women’s Health

18 March 2026
Trade Marks in FemTech: Building Brand Trust in Women’s Health banner
Trade Marks in FemTech: Building Brand Trust in Women’s Health banner
FemTech is rapidly expanding in Australia, with innovations emerging across diagnostics, materials science, digital health and technologies designed to address long‑neglected women’s health needs.
Jacqueline Leong headshot
Jacqueline Leong
Senior Associate

Co-author: Dr Marianne Repacholi, Senior Associate

As this sector grows and becomes more competitive, building a strong and recognisable brand is increasingly important. Trade marks play a key role in protecting that brand and securing a stronger market position as new products and services enter the market.

Many FemTech companies adopt names that feel familiar, supportive or feminine, reflecting the deeply personal nature of women’s health technologies. However, in a crowded market where many businesses use similar language around cycles, fertility, menopause, and wellness, it can become difficult for brands to stand out. Names that rely too heavily on descriptive terms may struggle to function effectively as trade marks, making them harder to register, easier for competitors to imitate and more difficult to enforce.

Selecting a distinctive brand from the outset can provide a powerful strategic advantage. A well-protected trade mark not only supports commercial growth and investment readiness, but also helps build the trust that is essential for women to adopt new technologies. In a sector where products often relate to highly personal health experiences, a credible and recognisable brand can be just as important as the underlying innovation.

As the FemTech ecosystem evolves, companies that take a thoughtful approach to brand development and trade mark protection will be better positioned to grow, collaborate and scale their technologies. Early guidance from a trade mark professional can help innovators navigate registrability issues, minimise risk, and develop a strategy that supports long‑term brand value and consumer confidence.

Related news and insights

Insights Photo

Otsuka Update: Special Leave Filed and IP Australia Refines PTE Processing Approach

The patentee has filed a special leave application to the High Court of Australia seeking to appeal the Full Court’s decision in Otsuka Pharmaceutical Co., Ltd v Sun Pharma ANZ Pty Ltd.
Dr Annabella Newton

4 March 2026

Insights Photo

Has the balance shifted? Federal Court grants first preliminary injunctions to pharmaceutical patentees since 2018

Two recent decisions of the Federal Court, AstraZeneca AB v Pharmacor Pty Ltd [2026] FCA 88 and Janssen Pharmaceutica NV v Juno Pharmaceuticals Pty Ltd [2025] FCA 1538 suggest the tide may be turning back to originators seeking preliminary injunctions (PIs) to restrain generic market entry.
Dr Christina Lucato

26 February 2026

Insights Photo

Why 2026 Will Be Big for Women’s Health Innovation

2026 is shaping up as a pivotal year for women’s health innovation, not because of any single technological breakthrough, but because the broader environment is changing.
Dr Marianne Repacholi

6 February 2026

Learn more about what matters to our people

We are a curious and approachable team of professionals, united by a passion for IP and helping your ideas succeed.

Banner image
How can we help you?